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Immunization of mice with peptide constructs, consisting of a determinant recog- 
nized by T cytotoxic cells colinearly linked to a determinant recognized by T helper 
cells (TD,-TD 1 
? 
was able to induce cytotoxic T lymphocytes in vivo. Interestingly, this 
induction cou d be achieved in the absence of adjuvant in non-depleted as well as in 
CD4+-cell-depleted BALB/c mice. In the latter case, induction took place simultane- 
ously with the activation of CD8+ T helper cells specific for a TD, contained within the 
sequence of the TD, RIQRGPGRAPVTIGK from the immunodommant V3 loop of HIV1 
gp120. The possible implications of these findings in HIV infection and AIDS disease 
are discussed. 
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INTRODUCTION 
Cytotoxic T lymphocytes (CTL) play an 
important role in the control of viral infections 
(Yap et al., 1978; Zinkemagel et al., 1979) and 
tnmour cell growth (Kast et al., 1989; Greenberg, 
1991). For these reasons, the understanding of 
how CTL are induced in viva is of paramount 
importance both for vaccine design and cancer 
therapy. 
CTL are usually induced following infection 
with a virus. Thus, cellular enzymes from 
infected cells process viral proteins into peptides. 
Some of these peptides, following association 
with MHC class I molecules are presented at the 
surface of the infected cell, which after recogni- 
tion by a specific T-cell receptor leads to CTL 
activation (Townsend et al., 1989). Immunization 
with inactivated virus or viral proteins does not 
usually induce CTL (Moore et al., 1988). This 
failure is probably due to lack of internalization 
of the antigen in the cytoplasm of the APC, 
where endogenous MHC class I processing takes 
place (Gething et al., 1978; Bangham et al., 
1985; Townsend et al., 1986). Since presentation 
of peptides linked to class I molecules is an 
essential step for CTL induction, several groups 
have developed different immunization strategies 
to achieve CTL induction in viva using peptides 
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emulsified in Freund’s adjuvants (Aichele et al., 
1990; Schulz et al., 1991; Fayole et al., 1991; 
Gao et al., 1991; Hart et al., 1991; Kast et al, 
1991), Iscoms (Takahashi et al., 1990b), Qss 
(Shirai et al., 1994), peptides encapsulated in 
liposomes (Watari et al., 1987), protein digests or 
synthetic peptide constructs in the absence of 
adjuvants (Ishioka et al., 1987; Carbone et al., 
1989; Lasarte et al., 1992). 
Besides the need for internalization of the anti- 
gen in the cell to gain access to the class I process- 
ing pathway, it has been reported that the helper 
activity (IL2 production) mediated by CD4+ cells 
is required to generate CTL in viva (Keene et al., 
1982; Leist et al., 1987, 1989). This suggests that 
induction of CTL by a peptide requires that both 
TD, and TDc moieties are contained in the pep- 
tide. Thus, Fayole et al. (1991) and Gao et al. 
(1991) have found that, after depleting mice of 
CD4+ cells in viva, no CTL activity could be 
induced by immunization with peptides. However, 
in other studies using live virus (Buller et al., 
1987; Moskophidis et al., 1987; Ahmed et al., 
1988; Mizuochi et al., 1989; Allan et al, 1990) or 
synthetic peptides (Vasilakos et al., 1993), in viva 
depletion of CD4+ cells did not significantly 
decrease CTL induction. These results suggested 
that there might be two pathways for CTL induc- 
tion, one dependent on and another independent 
of CD4+ T cells (Fayole et al, 1991). 
We provide experimental evidence that CTL 
can be induced in viva following immunization of 
mice with peptide construct of the type TDc-TD, 
in the absence of adjuvant. Moreover, this induc- 
tion was achieved in non-depleted as well as 
CD4+-cell-depleted BALB/c mice. In the latter 
case, CTL induction took place simultaneously 
with the activation of CD8+ T helper cells, which 
are specific for a TD, contained within the 
sequence of RIQRGPGRAFVTIGK, the region 
from the hypervariable V3 loop from HIV1 that 
also encompasses the TDc moiety used in the 
present study. These experiments show that CTL 
APC = antigen-presenting cell. 
CTL = cytotoxic T lymphocyte. 
TD = determinant recognized bv cvtotoxic T cells. 
induction with peptides may indeed take place 
via two different pathways: (i) a pathway where 
the T-cell help is provided by CD4+ T helper cells 
and (ii) a pathway independent of CD4+ T cells, 
where the T-cell help is provided by CD8+ T 
helper cells primed by the peptide. 
MATERIALS AND METHODS 
Peptide synthesis 
Peptides were synthesized by the solid phase 
method of Merrifield (1963) using the Fmoc altema- 
tive (Atherton et al., 1989). The synthesis was done 
manually and the ninhydrin test (Kaiser et al., 1970) 
was used to monitor every step. Couplings were 
repeated if necessary until a negative ninhydrin test 
was attained. Peptides were purified by high-perfor- 
mance liquid chromatography on a reverse-phase 
Cl8 column. 
Mice 
Female BALBlc and B 10A mice, 4-6 weeks old, 
were purchased from Panlab (Barcelona, Spain). 
Induction of CTL 
Groups of three female mice 4-weeks old were 
immunized three times at days 0, 7 and 14 by i.p. 
injection of 100 pg of peptide construct dissolved in 
0.5 ml of RPMI-1640 medium. At day 21, mice 
were killed and spleen cells removed and homoge- 
nized. Cells were harvested and cultured in vitro in 
the presence of 5 pg/ml of RIQRGPGRAFVTIGK 
peptide as described by Isbioka et al. (1987). Cyto- 
lytic activity was measured 5 days after initial cul- 
ture. The assays were done in triplicate. 
Anti-CD4 and anti-CDS monoclonal antibodies 
The L3T4 (CD4)-specific rat anti-mouse hybrid- 
oma GKl-5 and the CD8-specific rat anti-mouse 
hybridoma H35.17.2 were used to obtain anti-CD4 
and anti-CD8 antibodies. Ascitic fluid was obtained 
from nude mice pristane-primed and injected with lo6 
mll = determinant recognized by helper T cells. 
IL2 = interleukin-2. 
i-p. = intraperitoneal. 
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hybridoma cells. Antibodies were prepared by precip- restricted) previously incubated with 5 pg/ml of rel- 
itation with ammonium sulphate and dialysed against evant peptide were used. The assays were done in 
phosphate buffered saline. The protein concentration triplicate ; the spontaneous release was in all cases 
was assessed by measurement of the OD at 280 nm. below 20% of total release. 
Depletion of CD4+ and CDS+ cells in viva 
RESULTS 
Mice were depleted of CD4+ or CDS+ cells by i.p. 
injection of 300 pg of anti-CD4 or anti-CD8 antibod- 
ies, respectively, on days - 1, 0, 1, 6, 7, 8, 13, 14 and 
15 (Fayole et al., 1991). The efficiency of the deple- 
tion was assessed by flow cytometry on day 21. 
Induction of CTL in BALB/c mice using syn- 
thetic peptide constructs 
IL2 production assay 
Spleen cells were plated at 1 x lo6 cells per well 
in a final volume of 200 pl of culture medium in the 
presence or absence of different dilutions of peptide. 
Supernatants (50 p.1) were removed 24 h later and 
IL2 content was measured using a CTL.L bioassay 
as already described (Lai et al., 1987). 
Cytotoxic activity 
CTL activity was measured using the conven- 
tional cytotoxicity assay (Ishioka et al., 1987). Tar- 
get P815 cells (H-2d-restricted) or EL-4 (H-2b- 
We previously reported (Lasarte et al., 1992) 
that a CTL response could be induced in viva by 
immunization with the peptide construct 
RIQRGPGRAFVTIGKKQIINMWQEVG- 
KAMYA, hereafter referred to as RZQ-KQI, con- 
taining a TDc (in italics) and a TD, (KQI) from 
HIV1 gp160 (Takahashi et al, 1988; Cease et al., 
1987). To expand these results we carried out 
similar immunization experiments with another 
peptide construct RIQRGPGRAFVTIGKFI- 
SEAIIHVLHSR (RZQ-FIS) containing the same 
TDc but a different TD, (FE, residues 106-l 18 
from sperm whale myoglobin (Cease et al., 
1986)). Tables I and II show that peptides RZQ- 
Table I. Characterization of the cytotoxic and helper responses induced in non-depleted and CD4+- or CD8+- 
depleted BALB/c mice following immunization with RZQ-FIS. 
In vivo 
treatment 
In vitro 
treatment 
CTL activity IL2 production 
% specific lysis Restimulated with 
E:T Pulsed Peptide cont. 
ratio with RIQ Unpulsed (~g/ml) RrQ-fls RIQ FIS None 
None None 
Anti-CD4 
+anti- 
CD4 
+ anti- 
CD8 
None 
Anti-CD8 
+ anti- 
CD8 
None 
+ anti- 
CD4 
50 30 8 50 
16 17.5 5 10 
50 
10 
50 
10 
50 43 12 50 
16 36 6 10 
50 
10 
50 2 0.5 50 
16 3 0 10 
50 
10 
31,222 
18,994 
4,240 
2,419 
11,379 
6,911 
20,379 
11,968 
8,310 
6,438 
15,629 
10,197 
4,080 
1,638 
3,459 2,3 17 584 
718 531 
933 300 426 
553 322 
516 572 444 
669 375 
17,944 759 412 
10,687 713 
727 363 442 
764 405 
1,644 2,730 779 
1,128 1,453 
453 355 355 
439 463 
CTL activity is expressed as % of specific lysis of P815 target cells. IL2 production is expressed as incorporation of 3 H-thymidine 
in cpm by CTL.L cells (see “Materials and Methods”). This production was measured in the absence or in the presence of 100 pg/ml 
of anti-CD4 or anti-CD8 antibodies during in virro restimulations with the peptides shown. 
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Table II. Characterization of the cytotoxic and helper responses induced in non-depleted and CD4’- or CD8+- 
depleted BALBk mice following immunization with RZQ-KQI. 
In vivo 
treatment 
CTL activity IL2 production 
% specific lysis Restimulated with 
In vitro E:T Pulsed Peptide cont. 
treatment ratio with RZQ Unpulsed @g/ml) RZQ-KQI RZQ KQI None 
None None 
Anti-CD4 
+ anti- 
CD4 
+ anti- 
CD8 
None 
Anti-CD8 
+ anti- 
CD8 
None 
+ anti- 
CD4 
50 58 2 50 
16 36 0 10 
50 
10 
50 
10 
50 59 20 50 
16 32 6 
:i 
10 
5,389 1,480 3,753 2,469 
3,932 1,746 2,602 
678 400 722 360 
477 335 446 
3,168 1,550 2,730 1,355 
2,503 2,211 3,148 
11,894 21,097 804 604 
9,661 15,003 804 
881 1,201 393 239 
687 788 578 
50 0 1 50 1,602 1,014 715 1,068 
16 2 1 10 2,349 993 916 
50 451 722 632 903 
10 451 1,083 812 
Experimental conditions as in table I. 
FIS and RZQ-KQI were able to induce a CTL 
response against P8 15 target cells preincubated 
with RZQ. By contrast, free RZQ was unable to 
induce this response (table III). Induced CTL pre- 
sented the surface phenotype CD4-CD8+ as 
assessed by flow cytometry and by cytotoxic 
assays in the presence of anti-CD4 or anti-CD8 
antibodies plus complement. Induced CTL were 
able to lyse P8 15 preincubated with RIQ, but 
unable to lyse EL-4 cells, showing that they were 
H-2d-restricted (data not shown). 
CTL induction following depletion of CD4+ or 
CDS+ cells in BALB/c mice 
To study the role of CD4+ and CD8+ cells in 
CTL induction following immunization with 
RZQ-FIS and RI&-KQI, mice were depleted of 
CD4+ or CD8+ cells by i.p. injection of anti-CD4 
or anti-CD8 antibodies, respectively, as described 
in “Materials and Methods”. At day 21, mice 
were killed and the spleen cells removed and 
homogenized. Analysis of an aliquot of these 
cells by flow cytometry showed that depletion of 
CD4+ or CD8+ cells was, in all cases, at least 
95 % (data not shown). Following in vitro restim- 
ulation of the remaining spleen cells, under the 
conditions specified in “Materials and Methods”, 
CTL activity was measured. Tables I and II show 
that, both in RI&-FIS and RZQ-KQI immunized 
mice which had been depleted of CD4+ cells, 
CTL activity against P815 target cells incubated 
with RZQ was not lost, in contrast with the com- 
plete abrogation of activity observed in mice 
depleted of CD8+ cells. 
Effect of anti-IL2 receptor antibodies on CTL 
activity during in vitro restimulation 
In order to assess whether CTL induction was 
IL2-dependent during restimulations, the IL2 
receptor was blocked by adding anti-IL2 receptor 
antibodies. Figure 1 shows that following the 
addition of these antibodies to spleen cells from 
mice immunized with RI&-FIS, CTL induction 
was blocked, proving that the presence of IL2 is 
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Table III. Characterization of the cytotoxic and helper responses induced in non-depleted or CD4+-cell- 
depleted BALBk mice following immunization with RIQ. 
In vivo In vitro E:T 
treatment treatment ratio 
CTL activity IL2 production 
% specific lysis Restimulated with 
Pulsed Peptide cont. 
with RIQ Unpulsed @g/ml) RZQ None 
None None 
Anti-CD4 
+ anti- 
CD4 
+ anti- 
CD8 
None 
+ anti- 
CD8 
81 24 20 50 
27 11.2 10.9 10 
50 
10 
50 
10 
81 9.6 4.7 50 
27 1.0 0.5 10 
50 
10 
932 568 
1,197 
600 538 
323 
1,524 584 
1,052 
602 208 
381 
483 305 
480 
Experimental conditions as in table I. 
essential for in vitro expansion of the CTL 
induced in vivo. 
Effect of antXD4+ or anti-CDS+ addition on 
CTL activity during in vitro restimulation of 
cells from non-depleted immunized mice 
To study the effect of CD4+ and CD8+ cells 
during in vitro restimulation of spleen cells from 
RZQ-KQI immunized BALB/c mice (non- 
depleted of CD4+ or CD8+ cells), we added anti- 
CD4 or anti-CD8 antibodies (100 l.tg/ml, final 
concentration, of the corresponding antibody) to 
the in vitro restimulation medium. Table IV 
shows that both anti-CD4+ and anti-CD8+ anti- 
bodies abrogated CTL activity. 
IL2 production 
IL2 production was measured in parallel with 
CTL induction from cells induced following 
immunization with peptides. 
The results of these experiments are shown in 
tables I, II and III. Cells from normal mice (non- 
depleted of either CD4+ or CD8+ cells) immu- 
nized with RZQ-FIS produced high levels of IL2 
in the presence of RZQ-FIS (table I). This pro- 
duction was substantially blocked after adding 
anti-CD4 antibodies in vitro and, to a lesser 
extent, following the addition of anti-CD8 anti- 
bodies. It is interesting to note that IL2 produc- 
tion was mainly associated with RZQ-FIS, and 
that free RZQ and free FIS were much less 
active. 
In the group of non-depleted mice immunized 
with RI&-KQI (table II), it can be seen that 
restimulation with RZQ-KQI or with free KQI 
induced IL2 production, which was only twice 
that attained following restimulation without pep- 
tide. Mice immunized with RZQ, depleted or non- 
depleted of CD4+ cells, were unable to induce 
IL2 production (table III). 
Mice depleted of CD4+ cells in vivo and 
immunized with RZQ-FIS (table I) did not lose 
the ability to induce IL2 production following in 
vitro restimulation with RZQ-FIS. It is interest- 
ing to note that here RZQ was responsible for 
this induction. Also, IL2 production could be 
completely blocked by anti-CD8 antibodies if 
restimulations were carried out with RZQ. A 
substantial but incomplete decrease was 
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Fig. I. Effect of anti-IL2receptor antibodies on CTL acti- 
vity during in vitro restimulation. 
Spleen cells of BALB/c mice immunized with RZQ- 
F’IS were restimulated in vitro with RIQ (a) in the absence 
or (b) in the presence of anti-IL2-receptor antibodies. 
P815 target cells were preincubated with the antigens 
shown. 
observed when restimulation was carried out 
with RZQ-FIS. 
Mice depleted of CD4+ cells in vivo and 
immunized with RZQ-KQI (table II), showed a 
high level of IL2 production in the presence of 
RZQ peptide. This induction could be blocked 
almost completely by anti-CD8 antibodies, when 
RZQ-KQI or RZQ was used in the in vitro restim- 
ulations. 
Mice depleted of CD8+ cells in vivo and 
immunized with RZQ-FIS (table I) induced IL2 
production mainly when restimulated with RZQ- 
FIS. This induction was substantially decreased 
after adding anti-CD4 antibodies during in vitro 
Table IV. Effect of anti-CD4 or anti-CD8 antibody 
addition on CTL activity during in vitro restimu- 
lation of cells from non-depleted BALB/c mice 
immunized with RZQ-KQI. 
CTL activity 
% specific lysis 
In vitro E:T 
treatment ratio Pulsed with RZQ Unpulsed 
None 50 74 46 
16.6 38 21 
+anti-CD4 50 11 4 
16.6 2 1 
+ anti-CD8 50 6 2 
16.6 1 3 
Spleen cells were restimulated with RlQ in the absence or 
in the presence of 100 ug/ml of anti-CD4 or anti-CD8 antibo- 
dies. 
restimulation with peptide. Much poorer IL2 pro- 
duction was observed if restimulations were car- 
ried out with RZQ or FIS. This production could 
be completely blocked after adding anti-CD4 
antibodies. Similarly, when mice depleted of 
CD8+ cells were immunized with RI&-KQI 
(table II), RZQ-mediated IL2 production was lost, 
in contrast with the results obtained with mice 
depleted of CD4+ cells. 
Induction of CTL in BlOA mice (IAk, H-2d) 
with RI&-FIS; effect of in viva depletion of 
CD4+ cells on CTL induction and IL2 produc- 
tion 
It has been reported that RZQ is a TD, for 
CD4+ helper lymphocytes of BALB/c mice (Tak- 
ahashi et al., 1990a). However, RZQ is also recog- 
nized as TD, by CD8+ lymphocytes (tables I and 
II). In order to confirm the association of this 
TD, activity with MHC class I (H-2d) restriction, 
we immunized non-depleted and CD4+-cell- 
depleted BlOA mice (IAk, H-2d-restricted) with 
RI&-FIS. These mice share with BALB/c the 
class I restriction, but differ in their class II 
restriction. The CTL response as well as the IL2 
production in the presence of the different pep- 
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tides was studied. Table V shows that RZQ-FIS 
induced a significant cytotoxic response only in 
mice depleted of CD4 cells. IL2 production was 
also stronger in this group of mice and was 
mainly due to RZQ. This result confirms that the 
TD, character of RZQ is associated with CD8+ 
helper cells, and suggests that it is linked to MHC 
class I molecules. 
DISCUSSION 
In addition to internalization of the antigen in 
the cell in order to gain access to the class I pro- 
cessing pathway, activation of a helper response 
leading to the production of lymphokines is also 
essential for proliferation and maturation of CTLs 
(Keene et al., 1982; Leist et al., 1987, 1989). 
As was found for two synthetic peptides from 
LCMV and influenza virus (Fayole er aZ., 1991; 
Gao et al., 1991), and as suggested by us for the 
peptide construct RI&-KQI from HIV 1 gp120 
(Lasarte et al., 1992), induction of a CTL 
response with these synthetic peptides requires 
coactivation of a CD4 + helper response. More- 
over, the recent work of Shirai et al. (1994) with 
a similar peptide construct containing RZQ and 
KQI administered in QS21 saponine adjuvant has 
confirmed that help from CD4+ lymphocytes 
induced by the peptide construct is required. 
The results of IL2 production reported in 
tables I and II for non-depleted mice are essen- 
tially in agreement with the findings discussed 
above. Indeed, IL2 production by spleen cells 
from normal BALBlc mice immunized with RZQ- 
FIS or RZQ-KQI is dramatically decreased by 
adding anti-CD4 antibodies during in vitro 
restimulation. Moreover, in vitro addition of anti- 
ILZreceptor antibodies to spleen cells blocks the 
restimulation of CTL activity (fig. 1). This 
restimulation is also blocked by the addition of 
anti-CD4 as well as by anti-CD8 antibodies 
(table IV). All these observations suggest that 
CD4+ cells are required to provide T-cell help to 
CD8+ cytotoxic T cells. However, in some viral 
models, it has been observed that in viva deple- 
tion of CD4+ cells does not abrogate cytotoxic 
activity (Buller et al., 1987; Moskophidis et al., 
1987; Ahmed et al., 1988; Mizuochi et al., 1989; 
Allan et al., 1990). Also, it has been shown that 
CTL induction after a viral infection can be 
achieved in the absence of CD4+ cells when 
CD8+ cells produce the necessary lymphokines to 
support this induction (Mizuochi et al., 1989). To 
explain this apparent discrepancy concerning the 
role of CD4+ cells in CTL induction, it has been 
suggested that two different pathways of CTL 
induction may exist: one dependent on and 
another independent of CD4+-T-cell help (Fayole 
et al., 1991). 
To study in more detail the role of different 
cell populations in CTL induction using synthetic 
peptides, we analysed the effect of in viva CD4+ 
or CD8+ depletion. These experiments showed 
Table V. Characterization of the cytotoxic and helper responses induced in non-depleted or CD4+-depleted 
B 10A mice following immunization with RZ@FIS. 
In vivo E:T 
treatment ratio 
CTL activity IL2 production 
% specific lysis Restimulated with 
Pulsed Peptide cont. 
with RIQ Unpulsed CLg/ml RIQ-FB RIQ FW None 
None 25 10.7 6.1 50 2,394 858 820 644 
8.2 3.1 4.1 10 1,966 933 1,235 
Anti-CD4 20 19.0 0.1 50 6,711 4,640 968 950 
6.6 9.3 3.6 10 6,541 3,603 1,600 
Experimental conditions as in table I 
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that CD4+ depletion did not abrogate CTL induc- 
tion (tables I and II). Since lymphokines may be 
required in this process, we analysed IL2 produc- 
tion by spleen cells from different groups of mice 
immunized with peptides. As shown in tables I 
and II for in vivo CD4+-depleted mice, RZQ-FIS 
and RZQ-KQI constructs induced high levels of 
lL2. This production was mediated by RZQ and 
could be abrogated by the addition of anti-CD8 
antibodies. Moreover, in viva depletion of CD8+ 
cells abrogated IL2 production linked to RZQ. 
These results show that the luQ moiety contains 
a CD8+ helper determinant that may be impli- 
cated in in vim CTL induction. However, as 
shown in table III, immunizations of normal or 
CD4+-depleted BALB/c mice with free RIQ were 
unable to induce measurable CTL responses. This 
result has also been reported by Berzofsky 
(1991), Lasarte et al. (1992) and Shirai et al. 
(1994). We believe that this might be related to 
poor internalization of RZQ in the cells, thereby 
preventing their processing via the MHC class I 
pathway. 
Although the efficiency of in vivo CD4+ 
depletion was greater than 95% (as measured by 
flow cytometry; data not shown), it could be 
argued that IL2 production linked to RZQ in 
CD4+-depleted mice immunized with RIQ-FIS or 
RZQ-KQI may have been due to the remaining 
CD4+ cells. To show that IL2 production induced 
by RlQ was linked to class I molecules rather 
than to class II molecules, we immunized BlOA 
mice (IAk, H-2d) that share with BALB/c (IAd, 
H-2d) only the class I molecules. Thus, CD4+- 
depleted BlOA mice immunized with RI&-FIS 
elicited helper and cytotoxic T-cell responses 
linked to RZQ (table V), showing that these 
responses are associated with H-2d class I mole- 
cules. It is not clear why CD4+ depletion is 
required for induction of detectable specific lysis 
in BIOA mice. However, a tentative explanation 
might be the following: as shown in table V, 
immunization of normal BlOA mice with RZQ- 
FIS did not elicit T-cell help from either CD4+ or 
CD8+ cells. Thus, as expected, no CTL induction 
could take place due to the absence of this help. 
However, since T-cell help from CD8+ cells was 
elicited after depletion of CD4+ cells, this led to a 
concomitant induction of CTL. As opposed to 
BlOA mice, non-depleted BALB/c mice immu- 
nized with RZQ-FYI.5 were able to elicit T-cell help 
from CD4+ cells, and consequently CTL. How- 
ever, both in BlOA and BALB/c mice, the path- 
way of CTL induction linked to help from CDS+ 
cells takes place only after depletion of CD4+ 
cells (tables I, II and V). A possible interpretation 
of this result might be that CD4+ cells sequester 
the antigen, favouring the CD4+-cell-dependent 
pathway. Another alternative interpretation is that 
CD4+ cells might exert a suppressor effect on 
CD8+ cells. 
Under normal conditions (non-depleted mice), 
the induction of CTL seems to take place via the 
help from CD4+ cells. Indeed, as shown in 
table IV, the CTL activity induced in vivo in non- 
depleted mice can be abrogated by the addition of 
anti-CD4 antibodies during in vitro restimulation. 
This result is in agreement with that reported by 
Takahashi et al. (1990a) on CTL induction using 
recombinant vaccinia virus expressing HIV 1 
gp120. 
The appearance of AIDS in HIV-infected 
patients occurs when the cytotoxic activity and 
the CD4+ count are low (Gruters et aZ., 1991). 
However, the cytotoxic activity seems to remain 
unchanged for a long period of time, while the 
CD4+ count decreases progressively (Rowland- 
Jones and McMichael, 1993). It is tempting to 
postulate that the cytotoxic pathway independent 
of CD4+ helper cells that we found in CD4+- 
depleted mice might also be induced at this stage 
in HIV-infected patients. This might compensate 
over time for the loss of CD4+ T-cell help over a 
certain period of time. Moreover, as shown by 
Mizuochi et al. (1989) for the case of vaccinia 
virus infection, the activation of CTL via the 
CD8+ T helper pathway decreases progressively 
with increasing time. Based on the observation 
made by Moskophidis et al. (1993) for LCMV 
infection, showing that the disappearance of CTL 
activity is due to clonal deletion by exhaustion 
associated with high viral levels, it could be pos- 
tulated that the hypothetical CD4+-independent 
cytotoxic activity in AIDS might vanish due to 
this clonal deletion. However, if the CD4+-inde- 
pendent pathway for CTL activation has not been 
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induced in HIV-infected patients with a low 
CD4+ count, immunization of patients with pep- 
tide constructs like RZQ-KQI or RZQ-FIS at this 
stage, might offer some hope of keeping HIV at 
bay, thus delaying the appearance of AIDS. 
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L’induction in viva 
de lymphocytes T cytotoxiques 
est possible via la cellule T c( helper * CDS+ 
L’immunisation de la souris au moyen de pep- 
tides synthetiques ayant un determinant reconnu par 
les cellules T auxilliares, TD,-TD,, s’avere capable 
d’induire in vivo des lymphocytes T cytotoxiques. II 
est notable que cette induction aboutit en l’absence 
d’adjuvant, que la souris BALB/c soit porteuse ou 
depourvue de cellules CD4+ ; dans ce dernier cas, 
l’induction a lieu simultanr5ment avec l’activation de 
cellules T <<helper>> CD8+ specifiques du determi- 
nant TD, contenu dans la sequence RIQRGPGRAF- 
VTIGK correspondant au TD de la boucle V3 de 
la gp120 du VIH (virus de f’immunodeficience 
humaine). Les possibles implications de ces faits 
dans l’infection par le VIH et dans le SIDA sont 
discutees. 
Mats-cl&: VIH, Lymphocyte T, SIDA, IL2, 
Cytotoxicite ; Induction, CD8+, Cellules T auxilliai- 
res, Determinants, Glycoproteine gp120 du VIHl , 
Domaine V3, Peptides synthetiques, CMH, Souris, 
APC, CTL, Vaccins, Therapie anticancereuse. 
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